Dr. Uzoma N. Ibebuogu, MD

Dr. Ibebuogu practices at Methodist University Hospital in Memphis, Tennessee, part of Methodist Le Bonheur Healthcare.

Dr. Ibebuogu's NPI, 1265656672, was assigned on April 13, 2007. Dr. Ibebuogu holds Tennessee license 47640.

Dr. Ibebuogu's primary practice is Methodist University Hospital, at 1265 Union Ave Suite 700, Memphis, TN 38104 in Shelby County. The practice phone is (901) 516-8274.

Dr. Ibebuogu's primary practice is Methodist University Hospital in Memphis, Tennessee, part of Methodist Le Bonheur Healthcare. The medical group on file is Sutherland Cardiology Clinic - Wolf River. Dmand AI also links Dr. Ibebuogu to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ibebuogu practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Ibebuogu's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Ibebuogu's licenses on file in 2 states: Tennessee and Georgia.

CMS data shows 1,109 Medicare services from Dr. Ibebuogu across 15 procedure codes in 2024, for 672 Medicare patients. Medicare paid $54,351 for them.

CMS counts 672 Medicare patients who saw Dr. Ibebuogu in 2024. The largest group is 65 to 74, with 261 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ibebuogu's median patient age at 70, with 56% women.

In 2024, Dr. Ibebuogu wrote 2,046 Medicare Part D claims for 339 patients. 87% of them were for generic drugs. CMS names the drug for 1,900 of them, across 30 drugs with 11 or more claims each, at $281,665 in total drug cost. In 2023, CMS named 2,104 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Ibebuogu for performance year 2024, reported individually. Dr. Ibebuogu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 68 papers to Dr. Ibebuogu, published from 2011 to 2025. 2019 was the busiest year, with 8. The most frequent topics are Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis and Percutaneous Coronary Intervention. Dr. Ibebuogu has published most often in Curr Probl Cardiol. Dr. Ibebuogu's most frequent co-authors are Rami Nadim Khouzam, MD, Mark Reid Heckle, MD and Oluwaseun Ayodele Akinseye, MD.

Dmand AI links Dr. Ibebuogu to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Essential Hypertension and Hypertension.

CMS Open Payments shows 227 general payments to Dr. Ibebuogu from 19 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 65% of the total. Medtronic Vascular, Inc. paid the most, $9,747.